Published: 2022 June 06
Nasal Implants Market Size, Competitive Landscape and Market Forecast - 2030
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Global Nasal Implants Market is segmented By Material Type (Synthetic, Biological), By End Users (Hospitals and Clinic, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Nasal Implants Market Overview

The global nasal implants market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).      

Nasal implants are devices inserted in the nose following nasal or paranasal sinus surgery. These drug-eluting devices slowly and continuously release drug loads to impacted sinus or nasal cavity areas over an extended period from polymer matrices. Infections, inflammations, neoplasms, autoimmune illnesses, and nasal reconstruction for cosmetic defects are all treated locally with the devices. Sinusitis is also effectively treated with nasal implants.


Nasal Implants Market - Strategic Insights



Market CAGR


Segments Covered

By Treatment Type, By Type of Molecule, By Route of Administration, By End-User and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America


To Get a Free Sample Click here


Nasal Implants Market Dynamics

The global nasal implants market is driven by technological advancements, the growing nasal construction procedures, advanced nasal implants with biodegradable implants, and research to develop new natural forms of nasal implants.

Increasing benefits of nasal implants drive market growth    

The rising demand for nasal reconstruction procedures drives the market in the forecast period, as per the article published in the International Journal of Environmental Research and Public Health in 2021, maxillofacial defects caused by ablative tumor surgery, genetic malformations, and trauma. These defects require immediate intervention to enhance the quality of life of a patient. Nasal defects particularly affect the esthetics and psychology of patients due to their central location on the face. Among different retentive options, craniofacial implants have been reported to provide prostheses' optimum retention and stability. The most common implant locations to retain a nasal prosthesis are the anterior maxilla (floor of nasal cavity), zygomatic bone, and glabella. The success rate of the implant in the glabella region is lower than in the anterior maxilla, probably due to the bone's poor blood supply and density.

In addition, as per the article published in Clinical, Cosmetic and Investigational Dermatology in 2022, rhinoplasty is one of the most popular plastic surgeries. Rhinoplasty augmentation techniques have been developed over decades, and various materials have been used as synthetic nasal implants, including silicone, expanded polytetrafluoroethylene (ePTFE), and autologous cartilages. Among all, silicone implants have been most continually used in augmentation rhinoplasty in Asia. Silicone implants are inexpensive, convenient for carving to make a proper design, easily removable in case of side effects, and highly satisfactory in their design.

The side effects of Nasal Implants will hamper the growth of the market  

However, side effects after receiving the nasal implants include allergic reactions such as skin rash, changes in vision, eye pain, itching or hives, swelling of the face, lips, or tongue, movement of the implant (within or out of the sinus) and signs and symptoms of infection like fever or chills, cough, sore throat.

COVID-19 Impact Analysis on Nasal Implants Market

The appearance of COVID-19 considerably impacted the global medical aesthetics market. European healthcare systems face a backlog of surgical procedures following the suspension of routine surgery during the COVID-19 crisis. Routine rhinology surgery under general anesthetic (GA) faced significant challenges, including limited theatre capacity, the negative ramifications of surgical prioritization, reduced patient throughput in secondary care, and additional personal protective equipment requirements. Delayed rhinology surgery, particularly chronic rhinosinusitis, has previously been shown to have poorer surgical outcomes, a detrimental effect on the quality of life and long-term negative health socio-economic effects. Awake rhinology surgery under local anesthetic (LA) provides an ideal alternative to GA. It provides a means of operating on patients in a setting alternative to currently oversubscribed main theatres by utilizing satellite facilities while ensuring identical surgical outcomes for patients who may otherwise have been forced to wait a long time for their procedure. It also confers additional benefits regarding patients' shorter recovery time and hospital stay. 

Nasal Implants Market Segment Analysis

The biological segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)        

The biological segment accounts for the largest market share. As per the article publsihed in Brazilian Journal of Otorhinolaryngology, in 2020, rhinoplasty is the most common cosmetic surgery. Correction of nasal septal deformity is a challenge for aesthetic surgeons to deliver the best shape of the nose's bony and cartilaginous frameworks with minimal difficulties. Materials for reconstruction include autogenic and alloplastic grafts. Fewer infections, patient safety, and mild immunological response characterize autogenic transplantation of costal cartilage grafts. However, alloplastic grafts are more suitable in terms of less warping, unlike costal cartilage grafts, which may absorb or warp during the period after surgery. Several approaches are used to minimize graft-related warping to overcome these difficulties. The most routine is delay grafting or immersing the graft in a solution before shaping or insertion.

In addition, rhinoplasty is becoming more common among patients over 40 years. For cosmetic purposes, many women have sought a diversity of beautiful patterns. Although autogenic grafts are more commonly used than alloplastic grafts, alloplastic grafts are widely preferable in Asia over autogenic grafts.

Nasal Implants Market Geographical Analysis

North America region holds the largest market share of the global nasal implants market

North America dominates the market for nasal implants and is anticipated to show a similar trend over the forecast period. The market is driven by factors such as advanced healthcare infrastructure and key players' activities in the region. The market players are adopting market strategies such as collaboration and product launches to expand their business. For instance, in January 2021, Intersect ENT, Inc., a global ear, nose and throat medical technology leader devoted to changing patient care, reported that the Centers for Medicare and Medicaid Services had approved a revised coding application filed by the company for its family of PROPEL (mometasone furoate) sinus implants utilized to decrease inflammation and maintain patency following sinus surgery.

In May 2022, Medtronic plc (Dublin, Ireland) acquired Intersect ENT (Menlo Park, CA, USA), thereby expanding the company's comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve postoperative outcomes and to treat nasal polyps.

Intersect ENT's product lines and customer base will further Medtronic's efforts to positively impact patients who suffer from chronic rhinosinusitis (CRS). CRS is one of the most common healthcare problems in the United States, with around 30 million adults diagnosed each year. It is related to lost work days, decreased productivity, and even depression and anxiety, with most patients reporting 5-15+ years of suffering and medical treatment.

Through this acquisition, Medtronic gains PROPEL and SINUVA, unique bioabsorbable, steroid-eluting implants for sinus patients. PROPEL implants are inserted following endoscopic sinus surgery to maintain sinus patency and provide localized steroid delivery. SINUVA implants are developed for use in the physician's office setting to treat nasal polyps in adult patients who have had ethmoid sinus surgery.

Nasal Implants Companies & Competitive Landscape

The nasal implants market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Ethicon USA LLC, Implantech, Intersect ENT, Inc., Stryker Corporation, Zimmer Biomet, Allergan, Plc, Sientra, Inc., KLS Martin L.P, Medartis AG, TMJ Concepts, and Nagor, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the nasal implants market globally. 

Stryker Corporation


Stryker Corporation is a medical technologies corporation based in the United States and founded in 1941. The company provides products including nasal implants, nasal packing, imaging, surgical instruments & tools, balloon dilation, and cryotherapy. 

Product Portfolio:

LATERA:  The LATERA nasal implant supports the nose's upper and lower lateral cartilage, reinforcing the nasal wall like traditional cartilage and polymer grafts. Supporting the cartilage in this manner may reduce nasal airway obstruction symptoms and help patients breathe better.  

The global nasal implants market report would provide access to approximately 55+ market data tables, 40+ figures, and in the range of 200 (approximate) pages.  

Trending Topics:

Hand Therapy Egg Balls Market

BCG Vaccine Market

Tonsil and Adenoid Removal Products Market

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy